Detalhe da pesquisa
1.
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
J Am Soc Nephrol
; 34(10): 1733-1751, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560967
2.
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial.
Cytotherapy
; 24(12): 1259-1267, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999133
3.
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalities.
Cytotherapy
; 22(6): 313-321, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273232
4.
GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor.
Front Bioeng Biotechnol
; 10: 834267, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35356775